<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Med Educ</journal-id><journal-id journal-id-type="publisher-id">mededu</journal-id><journal-id journal-id-type="index">20</journal-id><journal-title>JMIR Medical Education</journal-title><abbrev-journal-title>JMIR Med Educ</abbrev-journal-title><issn pub-type="epub">2369-3762</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v10i1e54280</article-id><article-id pub-id-type="doi">10.2196/54280</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Naloxone Coprescribing and the Prevention of Opioid Overdoses: Quasi-Experimental Metacognitive Assessment of a Novel Education Initiative</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Enich</surname><given-names>Michael</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Morton</surname><given-names>Cory</given-names></name><degrees>MSW, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jermyn</surname><given-names>Richard</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><institution>Department of Internal Medicine, University of Washington</institution>, <addr-line>Seattle</addr-line><addr-line>WA</addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Center for Prevention Science, School of Social Work, Rutgers, The State University of New Jersey</institution>, <addr-line>390 George Street, 5th Floor</addr-line><addr-line>New Brunswick</addr-line><addr-line>NJ</addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Rowan-Virtua School of Osteopathic Medicine, Rowan University</institution>, <addr-line>Glassboro</addr-line><addr-line>NJ</addr-line>, <country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Lesselroth</surname><given-names>Blake</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Zakrocka</surname><given-names>Izabela</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Li</surname><given-names>Niying</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Linder</surname><given-names>Steven</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Cory Morton, MSW, PhD, Center for Prevention Science, School of Social Work, Rutgers, The State University of New Jersey, 390 George Street, 5th Floor, New Brunswick, NJ, 08901, United States, 1 8489327500, <email>cmorton@ssw.rutgers.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2024</year></pub-date><volume>10</volume><elocation-id>e54280</elocation-id><history><date date-type="received"><day>03</day><month>11</month><year>2023</year></date><date date-type="rev-recd"><day>31</day><month>07</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>08</month><year>2024</year></date></history><copyright-statement>&#x00A9; Michael Enich, Cory Morton, Richard Jermyn. Originally published in JMIR Medical Education (<ext-link ext-link-type="uri" xlink:href="https://mededu.jmir.org">https://mededu.jmir.org</ext-link>), 28.10.2024. </copyright-statement><copyright-year>2024</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Education, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://mededu.jmir.org/">https://mededu.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://mededu.jmir.org/2024/1/e54280"/><abstract><sec><title>Background</title><p>Critical evaluation of naloxone coprescription academic detailing programs has been positive, but little research has focused on how participant thinking changes during academic detailing.</p></sec><sec><title>Objective</title><p>The dual purposes of this study were to (1) present a metacognitive evaluation of a naloxone coprescription academic detailing intervention and (2) describe the application of a metacognitive evaluation for future medical education interventions.</p></sec><sec sec-type="methods"><title>Methods</title><p>Data were obtained from a pre-post knowledge assessment of a web-based, self-paced intervention designed to increase knowledge of clinical and organizational best practices for the coprescription of naloxone. To assess metacognition, items were designed with confidence-weighted true-false scoring. Multiple metacognitive scores were calculated: 3 content knowledge scores and 5 confidence-weighted true-false scores. Statistical analysis examined whether there were significant differences in scores before and after intervention. Analysis of overall content knowledge showed significant improvement at posttest.</p></sec><sec sec-type="results"><title>Results</title><p>There was a significant positive increase in absolute accuracy of participant confidence judgments, confidence in correct probability, and confidence in incorrect probability (all <italic>P</italic> values were &#x003C;.05). Overall, results suggest an improvement in content knowledge scores after intervention and, metacognitively, suggest that individuals were more confident in their answer choices, regardless of correctness.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Implications include the potential application of metacognitive evaluations to assess nuances in learner performance during academic detailing interventions and as a feedback mechanism to reinforce learning and guide curricular design.</p></sec></abstract><kwd-group><kwd>naloxone</kwd><kwd>coprescribing</kwd><kwd>prescription</kwd><kwd>academic detailing</kwd><kwd>metacognition</kwd><kwd>metacognitive evaluation</kwd><kwd>pharmacotherapy</kwd><kwd>pharmaceutic</kwd><kwd>pharmaceutical</kwd><kwd>education</kwd><kwd>educational intervention</kwd><kwd>opioid</kwd><kwd>opioid overdose</kwd><kwd>harm reduction</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>In 2020, of the 91,799 drug-related overdoses in the United States, 75% involved an opioid [<xref ref-type="bibr" rid="ref1">1</xref>]. Naloxone is an invaluable tool to prevent opioid overdose [<xref ref-type="bibr" rid="ref2">2</xref>], and coprescription initiatives (or programs to encourage providers to prescribe naloxone to patients receiving opioids) are a common, important intervention to reduce fatal overdoses. This is especially true in primary care settings, since eligible patients who meet the Centers for Disease Control and Prevention coprescription guidelines are underprescribed naloxone to take home [<xref ref-type="bibr" rid="ref3">3</xref>].</p><p>Academic detailing programs are educational outreach approaches used to improve clinician decision-making, and they have consistently shown a positive effect on altering prescriber behavior and clinical decision-making [<xref ref-type="bibr" rid="ref4">4</xref>]. Health systems have implemented naloxone coprescription academic detailing programs with demonstrated positive effects on the number of providers prescribing and patients receiving naloxone [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref5">5</xref>]. Critical evaluations of such programs have shown acceptability and feasibility of such interventions [<xref ref-type="bibr" rid="ref3">3</xref>], including positive impact on increasing the number of prescriptions despite hesitancy around the logistics of implementation [<xref ref-type="bibr" rid="ref6">6</xref>] and increasing the number of prescriptions after brief interventions [<xref ref-type="bibr" rid="ref7">7</xref>].</p><p>Learners in the health professions are important allies for combatting overdose; interventions have been developed for health profession students to be trained in overdose education and naloxone distribution [<xref ref-type="bibr" rid="ref8">8</xref>]. Results from student-focused overdose education and naloxone distribution interventions indicate increases in average participant knowledge around identifying and responding to suspected overdoses [<xref ref-type="bibr" rid="ref8">8</xref>]. To extend knowledge on changes in participant thinking during educational interventions, one area to consider is the effect on participant metacognition. Here, metacognition refers to the beliefs, attitudes, and confidence related to influencing a particular cognitive task, colloquially summarized as thinking about thinking. The measurement of participant metacognitive processes is especially important in health education because of the importance of the desired outcomes and the need for a life span approach to learning in the health professions. Improvements in metacognition in health education interventions have been linked to improved content knowledge acquisition, improved clinical reasoning, and decreased avoidable errors [<xref ref-type="bibr" rid="ref9">9</xref>]. However, assessing metacognition is not often a focus of medical education evaluation, and those who wish to evaluate metacognition are often met with a lack of clarity on how to effectively measure it [<xref ref-type="bibr" rid="ref10">10</xref>].</p><p>The dual purposes of this brief report are to (1) present a metacognitive evaluation of a naloxone coprescription academic detailing intervention for health professions students and practitioners and (2) describe the application of a metacognitive evaluation for future medical education interventions.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Data</title><p>Participants completed a self-paced, web-based academic detailing naloxone coprescription intervention implemented by Rowan University School of Osteopathic Medicine (RUSOM). This brief continuing medical education (CME)&#x2013;eligible course provided a standardized, evidence-based curriculum to train RUSOM&#x2013;affiliated health care providers, administrators, students, and executives across a variety of health care settings on how to implement and sustain naloxone coprescribing programs. Participants were recruited via email, and the only incentive was providing the CME credit at no cost. Consent was provided by agreeing to a question prompt to continue each survey after reading the informed consent documentation.</p><p>Data for this analysis came from a 20-item knowledge assessment based on the Centers for Disease Control and Prevention naloxone coprescription guidelines [<xref ref-type="bibr" rid="ref11">11</xref>], previously validated overdose knowledge assessment instruments [<xref ref-type="bibr" rid="ref12">12</xref>], as well as guidance based on best practices in implementation science [<xref ref-type="bibr" rid="ref13">13</xref>]. It was delivered in a pre-post design, where participants completed the knowledge assessment before accessing the educational intervention and after course completion. The course was designed as a single module to be completed in 1 session. Participants were eligible for CME credits after completion if they achieved a passing score; multiple individuals had more than 1 posttest score as they attempted to meet that minimum score. To avoid a bias in results, knowledge scores that came chronologically first were used as the posttest score in all analyses.</p><p>To assess metacognition, items were designed with confidence-weighted true-false (CTF) scoring, which combines traditional true-false questions with each learner&#x2019;s rated confidence for each item (I am confident this is true; I believe this is true, but I am unsure; I believe this is false, but I am unsure; and I am confident this is false). CTF is a useful and simple means to measure both cognitive and metacognitive achievements [<xref ref-type="bibr" rid="ref14">14</xref>].</p></sec><sec id="s2-2"><title>Study Sample</title><p>The sample includes any individual who completed both pre- and posttest assessments for the naloxone coprescription educational intervention between dates April 2020 and July 2021. To access the intervention, participants had to register via a university web application (from which voluntary demographic data were derived) and then log in to their learning management system. While the intervention provided an opportunity for CME credits, any individual was able to register for and take the course, including nonprescribers and students.</p></sec><sec id="s2-3"><title>Analysis</title><p>Descriptive statistics were calculated for individuals in the study sample. For both the pre- and posttest, 3 content knowledge scores were calculated: the summed CTF score (where confidently incorrect scores equal 0 points and confidently correct scores equal 4 points), the percent correct CTF score (based on maximum of 80), and the binary percent correct score (true/false [T/F]) (number correct regardless of confidence or number of items). In addition, metacognitive scores were calculated using the methods described by Dutke and Barenberg [<xref ref-type="bibr" rid="ref14">14</xref>] and included absolute accuracy of confidence judgments (AC), bias of confidence judgments (BS), confidence correct probability (CCP), confidence incorrect probability (CIP), and discrimination between correct and incorrect decisions (DIS). AC reflects the overall match between participant confidence and the outcome of their choice. An increase in AC suggests that individuals are better able to gauge both when they are confident in correct answers and unconfident in incorrect answers. BS is similar to AC but gives an indication of the direction and severity of participant ability to correctly asses their level of confidence in an answer. Values close to 0 indicate an exact match between confidence or nonconfidence and correctness or incorrectness, positive values suggest overconfidence (more confident but less correct), and negative values indicate underconfidence (less confident but more correct). However, the BS does not indicate the relative contribution of confidence to correct or incorrect answers, and the CCP and CIP are used to discern the respective probabilities of being confident that the answer is correct (CCP) or confident that the answer is incorrect (CIP). A higher CCP score indicates higher confidence when the answer is correct. A lower CIP score indicates less confidence when the answer is incorrect. A high CCP and low CIP suggests improvement in metacognition. Finally, the DIS is the difference between the CCP and CIP probabilities and is used to indicate how reliably a participant discriminates between correct and incorrect answers, with higher values indicating appropriate participant metacognitive monitoring and the ability to discriminate between concepts that are known and those that need reinforcement [<xref ref-type="bibr" rid="ref14">14</xref>]. To correct for a left-skewed distribution of assessment values, Wilcoxon signed rank analyses were applied to assess changes in individual scores between pre- and posttest assessments. Finally, Rosenthal correlations were calculated to determine the effect size of the intervention on each metacognitive score. Item-level examinations of CTF distribution were completed to add context to the metacognitive outcomes and identify concepts in the naloxone coprescription framework that may need reinforcement. McNemar tests were used to determine whether there was a significant change in correctness from pre- to posttest for each item. Statistical analyses were completed using Stata 17 (StataCorp LLC).</p></sec><sec id="s2-4"><title>Ethical Considerations</title><p>This study was approved by the Rutgers University Institutional Review Board (ID2019000275). Participants were provided informed consent at pretest and posttest, and data were deidentified prior to analysis. The course and CME credit were provided at no cost to participants, and no additional compensation was provided.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>Sample descriptive statistics are shown in <xref ref-type="table" rid="table1">Table 1</xref>; 307 individuals completed both pre- and posttests. As shown in <xref ref-type="table" rid="table2">Table 2</xref>, analysis of overall test scores showed a statistically significant improvement in content knowledge after completing the educational intervention, both in CTF score and binary correct-incorrect score. For both, the effect size of the intervention was moderate.</p><p>Significant differences in metacognitive scores suggest potential improvements in metacognitive monitoring occurred during the intervention. There is a statistically significant increase in absolute AC with a moderate effect size, suggesting that after intervention individuals are better able to gauge when they are <italic>confident</italic> in <italic>correct</italic> answers and <italic>unconfident</italic> in <italic>incorrect</italic> answers. For BS, median response values changed from negative to positive with a strong effect size, suggesting an overall change from being underconfident (negative values) in answer choices to appropriately confident (null or positive values) after intervention. Both CCP and CIP had a significant, positive change after intervention with strong effects. There was a significant decrease in DIS score after intervention with a very low effect size, which likely reflects an underlying increase in confidence in incorrect answers after academic detailing.</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows the CTF and binary T/F frequencies for each item and an indication of significant change from pre- to posttest using McNemar test. Most items saw their binary correct answers increase at posttest; only 1 item (item 15) saw a significant decline in correct answers (<italic>t</italic><sub>306</sub>=&#x2212;4.41; <italic>P</italic>=.04). This item was part of a conceptual group of questions (items 7, 12, and 15) on determining individual risk of overdose using the Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression (RIOSORD) tool. From a metacognitive perspective, this group of questions also saw the frequency of confident incorrect answers increase at posttest between 117% and 350%.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Demographic characteristics of participants (N=307).</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristics</td><td align="left" valign="bottom" colspan="2">Participants</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="3"><bold>Sex, n (%)</bold></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Male</td><td align="left" valign="top" colspan="2">77 (25.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Female</td><td align="left" valign="top" colspan="2">106 (34.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Undisclosed</td><td align="left" valign="top" colspan="2">124 (40.4)</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Race/ethnicity, n (%)</bold></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White/non-Hispanic</td><td align="left" valign="top" colspan="2">88 (28.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Black/non-Hispanic</td><td align="left" valign="top" colspan="2">18 (5.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Hispanic</td><td align="left" valign="top" colspan="2">13 (4.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Native American</td><td align="left" valign="top" colspan="2">3 (1.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Asian/Pacific Islander</td><td align="left" valign="top" colspan="2">4 (1.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Undisclosed</td><td align="left" valign="top" colspan="2">181 (59.0)</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Credentials, n (%)</bold></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Health professions students</td><td align="left" valign="top" colspan="2">213 (69.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Prescribers (MD<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup>, DO<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup>, NP-C<sup><xref ref-type="table-fn" rid="table1fn3">c</xref></sup>, or PA<sup><xref ref-type="table-fn" rid="table1fn4">d</xref></sup>)</td><td align="left" valign="top" colspan="2">48 (15.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Pharmacists</td><td align="left" valign="top" colspan="2">3 (1.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other health professional</td><td align="left" valign="top" colspan="2">4 (1.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Undisclosed</td><td align="left" valign="top" colspan="2">39 (12.7)</td></tr><tr><td align="left" valign="top"><bold>Age (years), mean (SD)</bold></td><td align="left" valign="top" colspan="2">32 (11.6)</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>MD: medical doctor.</p></fn><fn id="table1fn2"><p><sup>b</sup>DO: doctor of osteopathic medicine.</p></fn><fn id="table1fn3"><p><sup>c</sup>NP-C: nurse practitioner.</p></fn><fn id="table1fn4"><p><sup>d</sup>PA: physician&#x2019;s assistant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Naloxone coprescription program metacognitive scores (N=307).</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom"/><td align="left" valign="bottom" colspan="3">Preintervention</td><td align="left" valign="bottom" colspan="3">Postintervention</td><td align="left" valign="bottom"><italic>df</italic></td><td align="left" valign="bottom"><italic>z</italic></td><td align="left" valign="bottom">Effect size<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Median</td><td align="left" valign="top">IQR</td><td align="left" valign="top">Range</td><td align="left" valign="top">Median</td><td align="left" valign="top">IQR</td><td align="left" valign="top">Range</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr></thead><tbody><tr><td align="left" valign="top">CTF<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup> overall score</td><td align="left" valign="top">36</td><td align="left" valign="top">32 to 40</td><td align="left" valign="top">17 to 51</td><td align="left" valign="top">43</td><td align="left" valign="top">33 to 48</td><td align="left" valign="top">18 to 58</td><td align="left" valign="top">306</td><td align="left" valign="top">&#x2212;9.41<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2212;0.54 (moderate)</td></tr><tr><td align="left" valign="top">Binary true/false score</td><td align="left" valign="top">60</td><td align="left" valign="top">53.3 to 66.7</td><td align="left" valign="top">28.3 to 85</td><td align="left" valign="top">71.7</td><td align="left" valign="top">55 to 80</td><td align="left" valign="top">30 to 97</td><td align="left" valign="top">306</td><td align="left" valign="top">&#x2212;9.41<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2212;0.54 (moderate)</td></tr><tr><td align="left" valign="top">Absolute accuracy of confidence judgments</td><td align="left" valign="top">0.55</td><td align="left" valign="top">0.45 to 0.65</td><td align="left" valign="top">0.15 to 0.95</td><td align="left" valign="top">0.65</td><td align="left" valign="top">0.55 to 0.80</td><td align="left" valign="top">0.2 to 1</td><td align="left" valign="top">306</td><td align="left" valign="top">&#x2212;9.42<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2212;0.54 (moderate)</td></tr><tr><td align="left" valign="top">Bias of the confidence judgments</td><td align="left" valign="top">&#x2212;0.35</td><td align="left" valign="top">&#x2212;0.50 to &#x2212;0.10</td><td align="left" valign="top">&#x2212;0.85 to 0.65</td><td align="left" valign="top">0.10</td><td align="left" valign="top">&#x2212;0.15 to 0.25</td><td align="left" valign="top">&#x2212;0.80 to 0.70</td><td align="left" valign="top">306</td><td align="left" valign="top">&#x2212;13.08<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2212;0.75 (strong)</td></tr><tr><td align="left" valign="top">Confident correct probability</td><td align="left" valign="top">0.36</td><td align="left" valign="top">0.17 to 0.62</td><td align="left" valign="top">0 to 1</td><td align="left" valign="top">0.88</td><td align="left" valign="top">0.64 to 1</td><td align="left" valign="top">0 to 1</td><td align="left" valign="top">306</td><td align="left" valign="top">&#x2212;13.59<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2212;0.78 (strong)</td></tr><tr><td align="left" valign="top">Confident incorrect probability</td><td align="left" valign="top">0.14</td><td align="left" valign="top">0 to 0.43</td><td align="left" valign="top">0 to 1</td><td align="left" valign="top">0.80</td><td align="left" valign="top">0.38 to 1</td><td align="left" valign="top">0 to 1</td><td align="left" valign="top">306</td><td align="left" valign="top">&#x2212;12.82<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2212;0.73<break/>(strong)</td></tr><tr><td align="left" valign="top">Discrimination between correct and incorrect decisions</td><td align="left" valign="top">0.11</td><td align="left" valign="top">0 to 0.26</td><td align="left" valign="top">&#x2212;0.63 to 0.92</td><td align="left" valign="top">0</td><td align="left" valign="top">0&#x2010;0.21</td><td align="left" valign="top">&#x2212;0.54 to 1</td><td align="left" valign="top">306</td><td align="left" valign="top">2.85<sup><xref ref-type="table-fn" rid="table2fn4">d</xref></sup></td><td align="left" valign="top">0.16<break/>(weak)</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>Rosenthal correlation (1991).</p></fn><fn id="table2fn2"><p><sup>b</sup>CTF: confidence-weighted true-false.</p></fn><fn id="table2fn3"><p><sup>c</sup><italic>P</italic>&#x003C;.001.</p></fn><fn id="table2fn4"><p><sup>d</sup><italic>P</italic>&#x003C;.01 (for this entry: <italic>P</italic>=.004).</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Item-level frequency distribution of confidence-weighted true-false (CTF) and binary true (T)/false (F) choices at pre- and posttests (N=307).</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" rowspan="2"/><td align="left" valign="bottom" colspan="2">Pretest</td><td align="left" valign="bottom" colspan="2">Posttest</td><td align="left" valign="bottom" colspan="2">McNemar test on binary pre- and postperformance</td><td align="left" valign="bottom">Confident incorrect answers, % change</td></tr><tr><td align="left" valign="bottom">CTF (%)</td><td align="left" valign="bottom">Binary choice (%)</td><td align="left" valign="bottom">CTF (%)</td><td align="left" valign="bottom">Binary choice (%)</td><td align="left" valign="bottom">Test statistic</td><td align="left" valign="bottom"><italic>P</italic> value</td><td align="left" valign="bottom"/></tr></thead><tbody><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 1: Naloxone coprescription efforts have been shown to increase access to naloxone for high-risk patients only in primary care settings. [Correct: F]</bold></italic></td><td align="left" valign="top">2.47</td><td align="left" valign="top">.16</td><td align="left" valign="top">100</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">11</td><td align="left" valign="top" rowspan="2">True: 38</td><td align="left" valign="top">22</td><td align="left" valign="top" rowspan="2">True: 33</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">27</td><td align="left" valign="top">11</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">36</td><td align="left" valign="top" rowspan="2">False: 62</td><td align="left" valign="top">11</td><td align="left" valign="top" rowspan="2">False: 66</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">26</td><td align="left" valign="top">55</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 2: Higher doses of naloxone may be safely used if a person is suspected of overdosing from synthetic opioids such as Fentanyl. [Correct: T]</bold></italic></td><td align="left" valign="top">26.18</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">&#x2212;28.5</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">7</td><td align="left" valign="top" rowspan="2">False: 27</td><td align="left" valign="top">5</td><td align="left" valign="top" rowspan="2">False: 11</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">19</td><td align="left" valign="top">6</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">45</td><td align="left" valign="top" rowspan="2">True: 73</td><td align="left" valign="top">22</td><td align="left" valign="top" rowspan="2">True: 88</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">28</td><td align="left" valign="top">66</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 3: Clinicians can prescribe only naloxone to patients receiving opioid prescriptions. [Correct: F]</bold></italic></td><td align="left" valign="top">1.25</td><td align="left" valign="top">.26</td><td align="left" valign="top">64</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">11</td><td align="left" valign="top" rowspan="2">True: 28</td><td align="left" valign="top">18</td><td align="left" valign="top" rowspan="2">True: 26</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">17</td><td align="left" valign="top">8</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">30</td><td align="left" valign="top" rowspan="2">False: 72</td><td align="left" valign="top">12</td><td align="left" valign="top" rowspan="2">False: 75</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">42</td><td align="left" valign="top">63</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 4: A person under the influence of an opioid can be arrested and charged for being under the influence of a controlled substance if he or she seeks medical assistance for himself or herself or someone else. [Correct: F]</bold></italic></td><td align="left" valign="top">0.91</td><td align="left" valign="top">.34</td><td align="left" valign="top">5</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">6</td><td align="left" valign="top" rowspan="2">True: 22</td><td align="left" valign="top">14</td><td align="left" valign="top" rowspan="2">True: 21</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">16</td><td align="left" valign="top">7</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">21</td><td align="left" valign="top" rowspan="2">False: 78</td><td align="left" valign="top">5</td><td align="left" valign="top" rowspan="2">False: 80</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">57</td><td align="left" valign="top">75</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 5: The cheapest form of naloxone is the naloxone autoinjector made by Evzio. [Correct: F]</bold></italic></td><td align="left" valign="top">16.20</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">129</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">7</td><td align="left" valign="top" rowspan="2">True: 47</td><td align="left" valign="top">18</td><td align="left" valign="top" rowspan="2">True: 33</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">40</td><td align="left" valign="top">15</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">37</td><td align="left" valign="top" rowspan="2">False: 53</td><td align="left" valign="top">6</td><td align="left" valign="top" rowspan="2">False: 67</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">16</td><td align="left" valign="top">61</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 6: Writing a prescription for Evzio, Narcan, or generic will each result in a patient receiving the same product. [Correct: F]</bold></italic></td><td align="left" valign="top">13.23</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">82</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">17</td><td align="left" valign="top" rowspan="2">True: 56</td><td align="left" valign="top">31</td><td align="left" valign="top" rowspan="2">True: 44</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">39</td><td align="left" valign="top">13</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">29</td><td align="left" valign="top" rowspan="2">False: 44</td><td align="left" valign="top">13</td><td align="left" valign="top" rowspan="2">False: 55</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">15</td><td align="left" valign="top">42</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 7: Naloxone should be coprescribed to patients only with a RIOSORD</bold><sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup> <bold>score of &#x003E;18. [Correct: F]</bold></italic></td><td align="left" valign="top">0.81</td><td align="left" valign="top">.37</td><td align="left" valign="top">350</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">8</td><td align="left" valign="top" rowspan="2">True: 59</td><td align="left" valign="top">36</td><td align="left" valign="top" rowspan="2">True: 56</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">51</td><td align="left" valign="top">20</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">30</td><td align="left" valign="top" rowspan="2">False: 41</td><td align="left" valign="top">11</td><td align="left" valign="top" rowspan="2">False: 44</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">11</td><td align="left" valign="top">33</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 8: Facilitators involved in leading the implementation of a naloxone coprescribing program are limited to clinical staff. [Correct: F]</bold></italic></td><td align="left" valign="top">19.76</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">&#x2212;32</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">9</td><td align="left" valign="top" rowspan="2">True: 38</td><td align="left" valign="top">16</td><td align="left" valign="top" rowspan="2">True: 26</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">30</td><td align="left" valign="top">10</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">31</td><td align="left" valign="top" rowspan="2">False: 62</td><td align="left" valign="top">14</td><td align="left" valign="top" rowspan="2">False: 74</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">30</td><td align="left" valign="top">60</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 9: Academic detailing is a service provided by academic professionals (ie, faculty at educational institutions) who provide clinicians with information on new clinical guidelines and how to implement them. [Correct: T]</bold></italic></td><td align="left" valign="top">0.02</td><td align="left" valign="top">.88</td><td align="left" valign="top">300</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">1</td><td align="left" valign="top" rowspan="2">False: 7</td><td align="left" valign="top">4</td><td align="left" valign="top" rowspan="2">False: 7</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">6</td><td align="left" valign="top">3</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">58</td><td align="left" valign="top" rowspan="2">True: 93</td><td align="left" valign="top">20</td><td align="left" valign="top" rowspan="2">True: 93</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">35</td><td align="left" valign="top">73</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 10: A social marketing program for patients is likely to be more effective in a larger health system such as JerseyCare, as opposed to a smaller practice such as Johnson Family Practice. [Correct: F]</bold></italic></td><td align="left" valign="top">0.15</td><td align="left" valign="top">.70</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">16</td><td align="left" valign="top" rowspan="2">True: 54</td><td align="left" valign="top">35</td><td align="left" valign="top" rowspan="2">True: 56</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">38</td><td align="left" valign="top">21</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">34</td><td align="left" valign="top" rowspan="2">False: 46</td><td align="left" valign="top">18</td><td align="left" valign="top" rowspan="2">False: 44</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">12</td><td align="left" valign="top">26</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 11: Tailoring aspects of the naloxone coprescription checklist to accommodate your practice is not recommended because it will limit the effectiveness of the naloxone coprescription program. [Correct: F]</bold></italic></td><td align="left" valign="top">0.38</td><td align="left" valign="top">.54</td><td align="left" valign="top">&#x2212;6</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">7</td><td align="left" valign="top" rowspan="2">True: 35</td><td align="left" valign="top">21</td><td align="left" valign="top" rowspan="2">True: 33</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">27</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">41</td><td align="left" valign="top" rowspan="2">False: 65</td><td align="left" valign="top">17</td><td align="left" valign="top" rowspan="2">False: 67</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">24</td><td align="left" valign="top">50</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 12: The RIOSORD tool calculates a patient&#x2019;s risk of overdose according to his or her mental health comorbidities. [Correct: F]</bold></italic></td><td align="left" valign="top">8.56</td><td align="left" valign="top">.003</td><td align="left" valign="top">117</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">29</td><td align="left" valign="top" rowspan="2">True: 87</td><td align="left" valign="top">63</td><td align="left" valign="top" rowspan="2">True: 80</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">58</td><td align="left" valign="top">17</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">9</td><td align="left" valign="top" rowspan="2">False: 13</td><td align="left" valign="top">5</td><td align="left" valign="top" rowspan="2">False: 20</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">4</td><td align="left" valign="top">15</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 13: Developing a stakeholder analysis can be an effective way to both engage and motivate stakeholders as well as facilitate buy-in to your coprescribing program. [Correct: T]</bold></italic></td><td align="left" valign="top">18.67</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">&#x2212;33</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">3</td><td align="left" valign="top" rowspan="2">False: 12</td><td align="left" valign="top">2</td><td align="left" valign="top" rowspan="2">False: 4</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">10</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">56</td><td align="left" valign="top" rowspan="2">True: 88</td><td align="left" valign="top">17</td><td align="left" valign="top" rowspan="2">False: 96</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">32</td><td align="left" valign="top">79</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 14: Organizational Readiness Assessments allow facilitators to identify the likelihood that instituting a change in their practice will be successful. [Correct: T]</bold></italic></td><td align="left" valign="top">9.14</td><td align="left" valign="top">.003</td><td align="left" valign="top">&#x2212;50</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">2</td><td align="left" valign="top" rowspan="2">False: 7</td><td align="left" valign="top">1</td><td align="left" valign="top" rowspan="2">False: 3</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">6</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">57</td><td align="left" valign="top" rowspan="2">True: 93</td><td align="left" valign="top">17</td><td align="left" valign="top" rowspan="2">True: 98</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">36</td><td align="left" valign="top">81</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 15: Gap analyses reveal unmet gaps in naloxone coprescribing to patients with a RIOSORD score of &#x003E;18. [Correct: F]</bold></italic></td><td align="left" valign="top">4.41</td><td align="left" valign="top">.04</td><td align="left" valign="top">191</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">22</td><td align="left" valign="top" rowspan="2">True: 84</td><td align="left" valign="top">64</td><td align="left" valign="top" rowspan="2">True: 90</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">63</td><td align="left" valign="top">26</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">13</td><td align="left" valign="top" rowspan="2">False: 16</td><td align="left" valign="top">6</td><td align="left" valign="top" rowspan="2">False: 10</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">3</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 16: Studies show that patients prescribed naloxone are more likely to engage in risky opioid-related behaviors because of a decreased perception of risk. [Correct: F]</bold></italic></td><td align="left" valign="top">6.86</td><td align="left" valign="top">.009</td><td align="left" valign="top">45</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">11</td><td align="left" valign="top" rowspan="2">True: 34</td><td align="left" valign="top">16</td><td align="left" valign="top" rowspan="2">True: 27</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">23</td><td align="left" valign="top">11</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">35</td><td align="left" valign="top" rowspan="2">False: 66</td><td align="left" valign="top">12</td><td align="left" valign="top" rowspan="2">False: 73</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">31</td><td align="left" valign="top">61</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 17: Provider stigma is a barrier to coprescribing naloxone. [Correct: T]</bold></italic></td><td align="left" valign="top">14.29</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">50</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">2</td><td align="left" valign="top" rowspan="2">False: 14</td><td align="left" valign="top">3</td><td align="left" valign="top" rowspan="2">False: 5</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">12</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">29</td><td align="left" valign="top" rowspan="2">True: 86</td><td align="left" valign="top">9</td><td align="left" valign="top" rowspan="2">True: 96</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">57</td><td align="left" valign="top">87</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 18: The RE-AIM<sup><xref ref-type="table-fn" rid="table3fn2">b</xref></sup> framework is useful in structuring the evaluation and sustainability of your naloxone coprescription program. [Correct: T]</bold></italic></td><td align="left" valign="top">10.12</td><td align="left" valign="top">.002</td><td align="left" valign="top">0</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">1</td><td align="left" valign="top" rowspan="2">False: 9</td><td align="left" valign="top">1</td><td align="left" valign="top" rowspan="2">False: 3</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">8</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">58</td><td align="left" valign="top" rowspan="2">True: 91</td><td align="left" valign="top">21</td><td align="left" valign="top" rowspan="2">True: 97</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">32</td><td align="left" valign="top">76</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 19: Providers in private practice with &#x003C;10 staff members can implement the RE-AIM framework and naloxone coprescribing checklist effectively. [Correct: T]</bold></italic></td><td align="left" valign="top">2.06</td><td align="left" valign="top">.15</td><td align="left" valign="top">67</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">3</td><td align="left" valign="top" rowspan="2">False: 16</td><td align="left" valign="top">5</td><td align="left" valign="top" rowspan="2">False: 12</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">14</td><td align="left" valign="top">7</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">58</td><td align="left" valign="top" rowspan="2">True: 84</td><td align="left" valign="top">26</td><td align="left" valign="top" rowspan="2">True: 89</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">26</td><td align="left" valign="top">63</td></tr><tr><td align="left" valign="top" colspan="5"><italic><bold>Item 20: In order to have the best results, implementation frameworks must be used in full and should not be combined. [Correct: F]</bold></italic></td><td align="left" valign="top">6.88</td><td align="left" valign="top">.009</td><td align="left" valign="top">73</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure True</td><td align="left" valign="top">22</td><td align="left" valign="top" rowspan="2">True: 64</td><td align="left" valign="top">38</td><td align="left" valign="top" rowspan="2">True: 57</td><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/><td align="left" valign="top" rowspan="4"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure True</td><td align="left" valign="top">42</td><td align="left" valign="top">19</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Unsure False</td><td align="left" valign="top">28</td><td align="left" valign="top" rowspan="2">False: 36</td><td align="left" valign="top">19</td><td align="left" valign="top" rowspan="2">False: 44</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sure False</td><td align="left" valign="top">8</td><td align="left" valign="top">25</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>RIOSORD: Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression.</p></fn><fn id="table3fn2"><p><sup>b</sup>RE-AIM: reach, effectiveness, adoption, implementation, and maintenance.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>In summary, findings suggest that the naloxone coprescription academic detailing intervention was effective at delivering content area knowledge and stimulating metacognition about coprescription practices. From a knowledge gain perspective, the intervention saw increases in participant knowledge along the key objectives of a naloxone coprescription program. In addition, metacognitively, results suggest that individuals were more likely to be confident in their answer choices after the intervention. While the confidence gain was seen mostly among participants who chose correct answers, a small number of participants also became overconfident in their incorrect answers. This finding could support the development of refresher courses as a tactic to reexpose those who were overconfident to the material to correct any misunderstanding of course content [<xref ref-type="bibr" rid="ref15">15</xref>], and for naloxone-prescribing programs, refreshers would be needed to account for the changing nature of the naloxone marketplace or clinical guidelines for overdose risk. The absolute AC significantly improved after intervention. Participants were better able to confidently discern correct and incorrect answers at posttest.</p><p>Across medical education settings, metacognitive evaluations have been implemented successfully, which has resulted in improvements in metacognition itself [<xref ref-type="bibr" rid="ref16">16</xref>], the learning and retrieval of basic science information [<xref ref-type="bibr" rid="ref17">17</xref>], and moderation of performance test anxiety in observed clinical examinations [<xref ref-type="bibr" rid="ref18">18</xref>]. Even withstanding the complexity of metacognitive measurement concepts [<xref ref-type="bibr" rid="ref10">10</xref>], CTF presents itself as a simple mechanism for metacognitive evaluation available to medical educators and evaluators, allowing them to assess potential areas of weakness in content delivery and specific areas where students may struggle with concepts [<xref ref-type="bibr" rid="ref14">14</xref>]. Academic detailing programs applying metacognitive evaluative processes may be best served by developing feedback loops for learners and curriculum designers driven by the results CTF tests. In our results, learners were the most confident in incorrect answers for questions detailing the specifics of assessing individual risk of overdose. Feedback to learners could provide clarification on application of the RIOSORD tool through follow-up emails, refresher courses, or the development of learning communities to support implementation and adoption. Feedback to curriculum designers may prompt an evaluation of course content to identify what course updates were needed to ensure key concept delivery.</p><p>This specific intervention was self-paced and web-based, a common format available for CME. Electronic interventions have been shown to be no different for metacognition than in-person interventions, despite having no formal educator to guide the process [<xref ref-type="bibr" rid="ref19">19</xref>]. This is important evidence to bolster the benefit of web-based continuing education [<xref ref-type="bibr" rid="ref9">9</xref>], especially given the proliferation of web-based education that occurred during the COVID-19 pandemic [<xref ref-type="bibr" rid="ref20">20</xref>]. Evidence suggests that if learners are going to engage in a self-paced curriculum, adding a metacognitive layer forces learners to critically think about their content knowledge acquisition [<xref ref-type="bibr" rid="ref21">21</xref>]. The identified potential overconfidence observed in this study after receiving education is consistent with other metacognitive evaluations [<xref ref-type="bibr" rid="ref22">22</xref>].</p><p>This study is not without limitations. The evaluation used a 1-group pretest, posttest design, which limits generalizability of the findings. While the course on best practices for coprescribing was brief and designed to be completed in 1 session, it is unknown how or whether other naloxone initiatives may have influenced participants. The academic detailing program&#x2019;s enrollment was open to RUSOM and its affiliates; it is not possible to rule out selection bias as 1 factor influencing score improvements.</p><p>While metacognitive processing was shown to be important for behavior change, we do not have a long-term measure to determine whether the intervention resulted in increased naloxone prescription or even whether learners went on to implement coprescription initiatives in their practice settings. As referenced earlier, there are multiple ways to assess metacognition, of which CTF is one, and the validity of one accepted measure of metacognition has yet to be established. However, this particular method of assessing metacognition with multiple conceptual domains allows evaluators to use several diagnostic measures to understand the conditions under which knowledge gain is occurring in educational interventions. Future research could measure long-term changes in these particular scores, tracking metacognitive monitoring as skills are applied, and potentially correlate both cognitive and metacognitive changes with on-the-ground prescribing and implementation behaviors.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AC</term><def><p>accuracy of confidence judgments</p></def></def-item><def-item><term id="abb2">BS</term><def><p>bias of confidence judgments</p></def></def-item><def-item><term id="abb3">CCP</term><def><p>confidence correct probability</p></def></def-item><def-item><term id="abb4">CIP</term><def><p>confidence incorrect probability</p></def></def-item><def-item><term id="abb5">CME</term><def><p>continuing medical education</p></def></def-item><def-item><term id="abb6">CTF</term><def><p>confidence-weighted true-false</p></def></def-item><def-item><term id="abb7">DIS</term><def><p>discrimination between correct and incorrect decisions</p></def></def-item><def-item><term id="abb8">RIOSORD</term><def><p>Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression</p></def></def-item><def-item><term id="abb9">RUSOM</term><def><p>Rowan University School of Osteopathic Medicine</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="web"><article-title>Drug overdose</article-title><source>Centers for Disease Control</source><year>2022</year><access-date>2022-06-14</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/drugoverdose/deaths/index.html">https://www.cdc.gov/drugoverdose/deaths/index.html</ext-link></comment></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coffin</surname><given-names>PO</given-names> </name><name name-style="western"><surname>Behar</surname><given-names>E</given-names> </name><name name-style="western"><surname>Rowe</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain</article-title><source>Ann Intern Med</source><year>2016</year><month>08</month><day>16</day><volume>165</volume><issue>4</issue><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.7326/M15-2771</pub-id><pub-id pub-id-type="medline">27366987</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>CG</given-names> </name><name name-style="western"><surname>Rodriguez</surname><given-names>F</given-names> </name><name name-style="western"><surname>Carrington</surname><given-names>AC</given-names> </name><name name-style="western"><surname>Fagan</surname><given-names>EB</given-names> </name></person-group><article-title>Development of a targeted naloxone coprescribing program in a primary care practice</article-title><source>J Am Pharm Assoc (2003)</source><year>2017</year><volume>57</volume><issue>2S</issue><fpage>S130</fpage><lpage>S134</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2016.12.076</pub-id><pub-id pub-id-type="medline">28189537</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soumerai</surname><given-names>SB</given-names> </name><name name-style="western"><surname>Avorn</surname><given-names>J</given-names> </name></person-group><article-title>Principles of educational outreach (&#x2018;academic detailing&#x2019;) to improve clinical decision making</article-title><source>JAMA</source><year>1990</year><month>01</month><day>26</day><volume>263</volume><issue>4</issue><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="medline">2104640</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bounthavong</surname><given-names>M</given-names> </name><name name-style="western"><surname>Devine</surname><given-names>EB</given-names> </name><name name-style="western"><surname>Christopher</surname><given-names>MLD</given-names> </name><name name-style="western"><surname>Harvey</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Veenstra</surname><given-names>DL</given-names> </name><name name-style="western"><surname>Basu</surname><given-names>A</given-names> </name></person-group><article-title>Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration</article-title><source>Health Serv Res</source><year>2019</year><month>10</month><volume>54</volume><issue>5</issue><fpage>1055</fpage><lpage>1064</lpage><pub-id pub-id-type="doi">10.1111/1475-6773.13194</pub-id><pub-id pub-id-type="medline">31313839</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behar</surname><given-names>E</given-names> </name><name name-style="western"><surname>Rowe</surname><given-names>C</given-names> </name><name name-style="western"><surname>Santos</surname><given-names>GM</given-names> </name><etal/></person-group><article-title>Acceptability of naloxone co-prescription among primary care providers treating ppatients on long-term opioid therapy for pain</article-title><source>J Gen Intern Med</source><year>2017</year><month>03</month><volume>32</volume><issue>3</issue><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/s11606-016-3911-z</pub-id><pub-id pub-id-type="medline">27815762</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behar</surname><given-names>E</given-names> </name><name name-style="western"><surname>Rowe</surname><given-names>C</given-names> </name><name name-style="western"><surname>Santos</surname><given-names>GM</given-names> </name><name name-style="western"><surname>Santos</surname><given-names>N</given-names> </name><name name-style="western"><surname>Coffin</surname><given-names>PO</given-names> </name></person-group><article-title>Academic detailing pilot for naloxone prescribing among primary care providers in San Francisco</article-title><source>Fam Med</source><year>2017</year><month>02</month><volume>49</volume><issue>2</issue><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="medline">28218937</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moses</surname><given-names>TE</given-names> </name><name name-style="western"><surname>Moreno</surname><given-names>JL</given-names> </name><name name-style="western"><surname>Greenwald</surname><given-names>MK</given-names> </name><name name-style="western"><surname>Waineo</surname><given-names>E</given-names> </name></person-group><article-title>Developing and validating an opioid overdose prevention and response curriculum for undergraduate medical education</article-title><source>Subst Abuse</source><year>2022</year><volume>43</volume><issue>1</issue><fpage>309</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1080/08897077.2021.1941515</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medina</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Castleberry</surname><given-names>AN</given-names> </name><name name-style="western"><surname>Persky</surname><given-names>AM</given-names> </name></person-group><article-title>Strategies for improving learner metacognition in health professional education</article-title><source>Am J Pharm Educ</source><year>2017</year><month>05</month><volume>81</volume><issue>4</issue><fpage>78</fpage><pub-id pub-id-type="doi">10.5688/ajpe81478</pub-id><pub-id pub-id-type="medline">28630519</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akturk</surname><given-names>AO</given-names> </name><name name-style="western"><surname>Sahin</surname><given-names>I</given-names> </name></person-group><article-title>Literature review on metacognition and its measurement</article-title><source>Proc Soc Behav Sci</source><year>2011</year><volume>15</volume><fpage>3731</fpage><lpage>3736</lpage><pub-id pub-id-type="doi">10.1016/j.sbspro.2011.04.364</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names> </name><name name-style="western"><surname>Haegerich</surname><given-names>TM</given-names> </name><name name-style="western"><surname>Chou</surname><given-names>R</given-names> </name></person-group><article-title>CDC guideline for prescribing opioids for chronic pain&#x2014;United States, 2016</article-title><source>JAMA</source><year>2016</year><month>04</month><day>19</day><volume>315</volume><issue>15</issue><fpage>1624</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.1464</pub-id><pub-id pub-id-type="medline">26977696</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>AV</given-names> </name><name name-style="western"><surname>Strang</surname><given-names>J</given-names> </name><name name-style="western"><surname>Marsden</surname><given-names>J</given-names> </name></person-group><article-title>Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation</article-title><source>Drug Alcohol Depend</source><year>2013</year><month>09</month><day>1</day><volume>132</volume><issue>1-2</issue><fpage>383</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2013.02.007</pub-id><pub-id pub-id-type="medline">23453260</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Rycroft-Malone</surname><given-names>J</given-names> </name><name name-style="western"><surname>Bucknall</surname><given-names>T</given-names> </name></person-group><source>Models and Frameworks for Implementing Evidence-Based Practice: Linking Evidence to Action</source><year>2010</year><publisher-name>John Wiley &#x0026; Sons</publisher-name><fpage>288</fpage></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutke</surname><given-names>S</given-names> </name><name name-style="western"><surname>Barenberg</surname><given-names>J</given-names> </name></person-group><article-title>Easy and informative: using confidence-weighted true&#x2013;false items for knowledge tests in psychology courses</article-title><source>Psychol Learn Teach</source><year>2015</year><month>11</month><day>1</day><volume>14</volume><issue>3</issue><fpage>250</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1177/1475725715605627</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bushuveb</surname><given-names>S</given-names> </name><name name-style="western"><surname>Bansbach</surname><given-names>J</given-names> </name><name name-style="western"><surname>Bentele</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Overconfidence effects and learning motivation refreshing BLS: an observational questionnaire study</article-title><source>Resusc Plus</source><year>2023</year><volume>14</volume><fpage>100369</fpage><pub-id pub-id-type="doi">10.1016/j.resplu.2023.100369</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>WH</given-names> </name><name name-style="western"><surname>Vadivelu</surname><given-names>J</given-names> </name><name name-style="western"><surname>Daniel</surname><given-names>EGS</given-names> </name><name name-style="western"><surname>Sim</surname><given-names>JH</given-names> </name></person-group><article-title>Thinking about thinking: changes in first-year medical students&#x2019; metacognition and its relation to performance</article-title><source>Med Educ Online</source><year>2015</year><volume>20</volume><issue>1</issue><fpage>27561</fpage><pub-id pub-id-type="doi">10.3402/meo.v20.27561</pub-id><pub-id pub-id-type="medline">26314338</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hennrikus</surname><given-names>EF</given-names> </name><name name-style="western"><surname>Skolka</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Hennrikus</surname><given-names>N</given-names> </name></person-group><article-title>Applying metacognition through patient encounters and illness scripts to create a conceptual framework for basic science integration, storage, and retrieval</article-title><source>J Med Educ Curric Dev</source><year>2018</year><volume>5</volume><fpage>2382120518777770</fpage><pub-id pub-id-type="doi">10.1177/2382120518777770</pub-id><pub-id pub-id-type="medline">29845119</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x2019;Carroll</surname><given-names>PJ</given-names> </name><name name-style="western"><surname>Fisher</surname><given-names>P</given-names> </name></person-group><article-title>Metacognitions, worry and attentional control in predicting OSCE performance test anxiety</article-title><source>Med Educ (Chicago Ill)</source><year>2013</year><volume>47</volume><issue>6</issue><fpage>562</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1111/medu.12125</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Norman</surname><given-names>E</given-names> </name></person-group><article-title>The relationship between metacognitive experiences and learning: is there a difference between digital and non-digital study media?</article-title><source>Comput Hum Behav</source><year>2016</year><volume>9</volume><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.chb.2015.07.043</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kansal</surname><given-names>AK</given-names> </name><name name-style="western"><surname>Gautam</surname><given-names>J</given-names> </name><name name-style="western"><surname>Chintalapudi</surname><given-names>N</given-names> </name><name name-style="western"><surname>Jain</surname><given-names>S</given-names> </name><name name-style="western"><surname>Battineni</surname><given-names>G</given-names> </name></person-group><article-title>Google trend analysis and paradigm shift of online education platforms during the COVID-19 pandemic</article-title><source>Infect Dis Rep</source><year>2021</year><volume>13</volume><issue>2</issue><fpage>418</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.3390/idr13020040</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuysuzoglu</surname><given-names>BB</given-names> </name><name name-style="western"><surname>Greene</surname><given-names>JA</given-names> </name></person-group><article-title>An investigation of the role of contingent metacognitive behavior in self-regulated learning</article-title><source>Metacogn Learn</source><year>2015</year><volume>10</volume><issue>1</issue><fpage>77</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s11409-014-9126-y</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Hoyer</surname><given-names>JF</given-names> </name><name name-style="western"><surname>Kimmerle</surname><given-names>J</given-names> </name><name name-style="western"><surname>Holtz</surname><given-names>P</given-names> </name></person-group><article-title>Acquisition of false certainty: learners increase their confidence in the correctness of incorrect answers after online information search</article-title><source>Comput Assist Learn</source><year>2022</year><volume>38</volume><issue>3</issue><fpage>833</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1111/jcal.12657</pub-id></nlm-citation></ref></ref-list></back></article>